Evidence map›Paper›PMID 39980427›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2025

Adenovirus type 7d outbreak associated with severe clinical presentation, Finland, February to June 2024.

Santtu Heinonen, Elina Erra, Richard Lundell, Aino Nyqvist, Pilvi Hepo-Oja, Laura Mannonen, Hanna Jarva, Raisa Loginov, Erika Lindh, Leif Lakoma and 9 more

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Santtu HeinonenDepartment of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Elina ErraDivision of Infectious Diseases, Inflammation Center, Helsinki University Hospital, Helsinki, Finland.
Richard LundellCentre for Military Medicine, Finnish Defence Forces, Helsinki, Finland.
Aino NyqvistDepartment of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Pilvi Hepo-OjaDepartment of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Laura MannonenHUS Diagnostic Center, Department of Clinical Microbiology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Hanna JarvaHUS Diagnostic Center, Department of Clinical Microbiology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Raisa LoginovHUS Diagnostic Center, Department of Clinical Microbiology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Erika LindhDepartment of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Leif LakomaDepartment of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Petri KangaspuntaCentre for Military Medicine, Finnish Defence Forces, Helsinki, Finland.
Ilkka LaaksiCentre for Military Medicine, Finnish Defence Forces, Helsinki, Finland.
Marjaana PitkäpaasiCentre for Military Medicine, Finnish Defence Forces, Helsinki, Finland.
Carita Savolainen-KopraDepartment of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Simo NikkariCentre for Military Medicine, Finnish Defence Forces, Helsinki, Finland.
Hanna NohynekDepartment of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Otto HelveDepartment of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Eeva RuotsalainenDivision of Infectious Diseases, Inflammation Center, Helsinki University Hospital, Helsinki, Finland.
Niina IkonenDepartment of Public Health, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report an adenovirus outbreak with unusually severe clinical presentation, particularly in military conscripts and their close contacts. During 1 February-30 June 2024, 129 patients with adenovirus infection were hospitalised, 30 were admitted to ICU, 10 required ECMO treatment and six died. Cases consisted of 75 conscripts (58.1%) and 54 civilians (41.9%). Most samples were type 7 (97/108; 89.8%); all 24 sequenced samples were subtype 7d. During 1 August-30 November 2024, 274 additional hospitalised cases were identified from registries.

Indexed as

AdenoviridaeAdenoviridae InfectionsAdenoviruses, HumanAdenovirus Infections, HumanDisease OutbreaksMilitary PersonnelAdolescentAdultExtracorporeal Membrane OxygenationFemaleFinlandHospitalizationHumansIntensive Care UnitsMaleYoung Adultadenovirusgarrisonmilitaryoutbreaktype 7d

Identifiers

PMID39980427
PMCPMC11843622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.